Revenue
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Boston Scientific Corp (BSX)
Price$44.64−1.18 (−2.58%)
Net income
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20.07B | $16.75B | $14.24B | $12.68B | $11.89B | $9.91B | $10.73B | $9.82B | $9.05B | $8.39B | $8.07B | $7.46B | $7.07B | $6.96B | $7.62B | $7.81B | $8.19B | $8.05B | $8.36B |
| Gross profit | $13.85B | $11.49B | $9.90B | $8.73B | $8.18B | $6.45B | $7.62B | $7.01B | $6.46B | $5.96B | $5.30B | $5.17B | $4.97B | $4.90B | $4.96B | $5.21B | $5.61B | $5.58B | $6.01B |
| Gross margin | 69.01% | 68.61% | 69.49% | 68.81% | 68.78% | 65.05% | 70.98% | 71.37% | 71.34% | 71.09% | 65.74% | 69.28% | 70.26% | 70.42% | 65.11% | 66.71% | 68.54% | 69.33% | 71.98% |
| Research & development | $2.05B | $1.61B | $1.41B | $1.32B | $1.20B | $1.14B | $1.17B | $1.11B | $997.0M | $920.0M | $876.0M | $817.0M | $861.0M | $886.0M | $895.0M | $939.0M | $1.03B | $1.01B | $1.09B |
| Operating expenses | $10.24B | $8.89B | $7.55B | $7.08B | $6.98B | $6.53B | $6.10B | $5.50B | $5.17B | $5.51B | $5.59B | $5.47B | $4.85B | $8.77B | $4.06B | $5.86B | $6.51B | $7.09B | $6.03B |
| Operating income | $3.61B | $2.60B | $2.34B | $1.65B | $1.20B | −$80.0M | $1.52B | $1.51B | $1.28B | $447.0M | −$283.0M | −$301.0M | $120.0M | −$3.87B | $904.0M | −$656.0M | −$894.0M | −$1.50B | −$14.0M |
| Operating margin | 18.00% | 15.54% | 16.45% | 13.00% | 10.09% | −0.81% | 14.14% | 15.33% | 14.20% | 5.33% | −3.51% | −4.03% | 1.70% | −55.59% | 11.86% | −8.40% | −10.92% | −18.70% | −0.17% |
| EBITDA | $4.98B | $3.87B | $3.54B | $2.79B | $2.29B | $1.04B | $2.53B | $2.40B | $2.13B | $1.26B | $486.0M | $424.0M | $809.0M | −$3.19B | $1.62B | $160.0M | −$60.0M | −$641.0M | $904.0M |
| EBITDA margin | 24.81% | 23.12% | 24.85% | 21.96% | 19.28% | 10.52% | 23.56% | 24.43% | 23.53% | 15.05% | 6.02% | 5.68% | 11.44% | −45.77% | 21.27% | 2.05% | −0.73% | −7.96% | 10.82% |
| Net income | $2.89B | $1.85B | $1.59B | $698.0M | $1.04B | −$82.0M | $4.70B | $1.67B | $104.0M | $347.0M | −$239.0M | −$119.0M | −$121.0M | −$4.07B | $441.0M | −$1.06B | −$1.02B | −$2.04B | −$495.0M |
| Net profit margin | 14.41% | 11.02% | 11.18% | 5.50% | 8.76% | −0.83% | 43.78% | 17.01% | 1.15% | 4.14% | −2.96% | −1.59% | −1.71% | −58.47% | 5.79% | −13.64% | −12.52% | −25.29% | −5.92% |
| Basic EPSper basic share | $1.96 | $1.26 | $1.08 | $0.45 | $0.69 | -$0.08 | $3.38 | $1.21 | $0.08 | $0.26 | -$0.18 | -$0.09 | -$0.09 | -$2.89 | $0.29 | -$0.70 | -$0.68 | -$1.36 | -$0.33 |
| Diluted EPSper diluted share | $1.94 | $1.25 | $1.07 | $0.45 | $0.69 | -$0.08 | $3.33 | $1.19 | $0.08 | $0.25 | -$0.18 | -$0.09 | -$0.09 | -$2.89 | $0.29 | -$0.70 | -$0.68 | -$1.36 | -$0.33 |
Owners
Reported shareholders
≈8.95%of listed shares
BlackRock, Inc.129.68M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
BlackRock, Inc. | ≈8.95%129.68M shares |
VANGUARD CAPITAL MANAGEMENT LLC | ≈6.70%97.09M shares |
STATE STREET CORP | ≈4.84%70.11M shares |
PRIMECAP MANAGEMENT CO/CA/ | ≈3.49%50.52M shares |
FMR LLC | ≈3.15%45.7M shares |
GEODE CAPITAL MANAGEMENT, LLC | ≈2.31%33.44M shares |
VANGUARD PORTFOLIO MANAGEMENT LLC | ≈2.06%29.79M shares |
D. E. Shaw & Co., Inc. | ≈1.76%25.46M shares |
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | ≈1.72%24.86M shares |
JPMORGAN CHASE & CO | ≈1.65%23.91M shares |
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | ≈1.61%23.29M shares |
NORGES BANK | ≈1.46%21.17M shares |
TWO SIGMA INVESTMENTS, LP | ≈1.34%19.36M shares |
MORGAN STANLEY | ≈1.31%18.95M shares |
Jupiter Topco LLC | ≈1.30%18.82M shares |
Bollard Group LLC | ≈1.27%18.42M shares |
GOLDMAN SACHS GROUP INC | ≈1.17%16.95M shares |
Capital World Investors | ≈1.16%16.81M shares |
UBS Group AG | ≈1.13%16.35M shares |
WELLINGTON MANAGEMENT GROUP LLP | ≈1.06%15.3M shares |
Percentages use 1.45B shares of this listed class outstanding on Jul 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Oct 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Aug 25, 2026Form 4 | Morano Susan EDirector | BuyCommon Stock | 2.0K | $49.22 | $100.4K | 13.8K |
| Aug 5, 2026Form 4 | Habiger David CDirector | BuyCommon Stock | 2.1K | $47.59 | $99.9K | 17.2K |
| Aug 4, 2026Form 4 | Habiger David CDirector | BuyCommon Stock | 140 | $48.59 | $6.8K | 15.1K |
| Aug 3, 2026Form 4 | Habiger David CDirector | BuyCommon Stock | 1.0K | $48.07 | $50.1K | 14.9K |
| Aug 3, 2026Form 4 | Mahoney Michael FChairman, President & CEO | BuyCommon Stock | 186.2K | $48.33 | $9.00M | 1.59M |